These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

336 related articles for article (PubMed ID: 26996382)

  • 21. Establishing a versatile toolkit of flux enhanced strains and cell extracts for pathway prototyping.
    Yi X; Rasor BJ; Boadi N; Louie K; Northen TR; Karim AS; Jewett MC; Alper HS
    Metab Eng; 2023 Nov; 80():241-253. PubMed ID: 37890611
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Spatial organization of heterologous metabolic system in vivo based on TALE.
    Zhu LY; Qiu XY; Zhu LY; Wu XM; Zhang Y; Zhu QH; Fan DY; Zhu CS; Zhang DY
    Sci Rep; 2016 May; 6():26065. PubMed ID: 27184291
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Engineering the biological conversion of methanol to specialty chemicals in Escherichia coli.
    Whitaker WB; Jones JA; Bennett RK; Gonzalez JE; Vernacchio VR; Collins SM; Palmer MA; Schmidt S; Antoniewicz MR; Koffas MA; Papoutsakis ET
    Metab Eng; 2017 Jan; 39():49-59. PubMed ID: 27815193
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Total in vitro biosynthesis of the nonribosomal macrolactone peptide valinomycin.
    Zhuang L; Huang S; Liu WQ; Karim AS; Jewett MC; Li J
    Metab Eng; 2020 Jul; 60():37-44. PubMed ID: 32224263
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CRISPR interference-guided balancing of a biosynthetic mevalonate pathway increases terpenoid production.
    Kim SK; Han GH; Seong W; Kim H; Kim SW; Lee DH; Lee SG
    Metab Eng; 2016 Nov; 38():228-240. PubMed ID: 27569599
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cell-free biosynthesis of limonene using enzyme-enriched
    Dudley QM; Nash CJ; Jewett MC
    Synth Biol (Oxf); 2019; 4(1):ysz003. PubMed ID: 30873438
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Metabolic engineering of Escherichia coli for improving shikimate synthesis from glucose.
    Chen X; Li M; Zhou L; Shen W; Algasan G; Fan Y; Wang Z
    Bioresour Technol; 2014 Aug; 166():64-71. PubMed ID: 24905044
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vitro metabolic engineering for the production of α-ketoglutarate.
    Beer B; Pick A; Sieber V
    Metab Eng; 2017 Mar; 40():5-13. PubMed ID: 28238759
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Biotin-independent strains of Escherichia coli for enhanced streptavidin production.
    Jeschek M; Bahls MO; Schneider V; Marlière P; Ward TR; Panke S
    Metab Eng; 2017 Mar; 40():33-40. PubMed ID: 28062280
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A synthetic O2 -tolerant butanol pathway exploiting native fatty acid biosynthesis in Escherichia coli.
    Pásztor A; Kallio P; Malatinszky D; Akhtar MK; Jones PR
    Biotechnol Bioeng; 2015 Jan; 112(1):120-8. PubMed ID: 24981220
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Metabolic engineering of Escherichia coli for microbial synthesis of monolignols.
    Chen Z; Sun X; Li Y; Yan Y; Yuan Q
    Metab Eng; 2017 Jan; 39():102-109. PubMed ID: 27816771
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Establishing a High-Yielding Cell-Free Protein Synthesis Platform Derived from Vibrio natriegens.
    Des Soye BJ; Davidson SR; Weinstock MT; Gibson DG; Jewett MC
    ACS Synth Biol; 2018 Sep; 7(9):2245-2255. PubMed ID: 30107122
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An integrated in vivo/in vitro framework to enhance cell-free biosynthesis with metabolically rewired yeast extracts.
    Rasor BJ; Yi X; Brown H; Alper HS; Jewett MC
    Nat Commun; 2021 Aug; 12(1):5139. PubMed ID: 34446711
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Metabolic engineering of cofactor flavin adenine dinucleotide (FAD) synthesis and regeneration in Escherichia coli for production of α-keto acids.
    Hou Y; Hossain GS; Li J; Shin HD; Du G; Chen J; Liu L
    Biotechnol Bioeng; 2017 Sep; 114(9):1928-1936. PubMed ID: 28498544
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Engineering cytosolic acetyl-coenzyme A supply in Saccharomyces cerevisiae: Pathway stoichiometry, free-energy conservation and redox-cofactor balancing.
    van Rossum HM; Kozak BU; Pronk JT; van Maris AJA
    Metab Eng; 2016 Jul; 36():99-115. PubMed ID: 27016336
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Model-based metabolic engineering enables high yield itaconic acid production by Escherichia coli.
    Harder BJ; Bettenbrock K; Klamt S
    Metab Eng; 2016 Nov; 38():29-37. PubMed ID: 27269589
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pathway construction and metabolic engineering for fermentative production of ectoine in Escherichia coli.
    Ning Y; Wu X; Zhang C; Xu Q; Chen N; Xie X
    Metab Eng; 2016 Jul; 36():10-18. PubMed ID: 26969253
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Engineering Escherichia coli to produce branched-chain fatty acids in high percentages.
    Bentley GJ; Jiang W; Guamán LP; Xiao Y; Zhang F
    Metab Eng; 2016 Nov; 38():148-158. PubMed ID: 27421620
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Improved n-butanol tolerance in Escherichia coli by controlling membrane related functions.
    Bui le M; Lee JY; Geraldi A; Rahman Z; Lee JH; Kim SC
    J Biotechnol; 2015 Jun; 204():33-44. PubMed ID: 25858152
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Engineering microbes for isoprene production.
    Ye L; Lv X; Yu H
    Metab Eng; 2016 Nov; 38():125-138. PubMed ID: 27424210
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.